James C. Mullen - CEO, Director at Editas Medicine, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Stock Symbol
EDIT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James C. Mullen since 11/24/2023

Holdings reported by James C. Mullen for Editas Medicine, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (right to buy) 171K Apr 14, 2022 Direct Common Stock

Transactions reported by James C. Mullen for Editas Medicine, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.